These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

801 related items for PubMed ID: 23747045

  • 41. Characterization of a Mouse Model of Alzheimer's Disease Expressing Aβ4-42 and Human Mutant Tau.
    Zampar S, Wirths O.
    Int J Mol Sci; 2021 May 14; 22(10):. PubMed ID: 34069029
    [Abstract] [Full Text] [Related]

  • 42. Voluntary Running Attenuates Memory Loss, Decreases Neuropathological Changes and Induces Neurogenesis in a Mouse Model of Alzheimer's Disease.
    Tapia-Rojas C, Aranguiz F, Varela-Nallar L, Inestrosa NC.
    Brain Pathol; 2016 Jan 14; 26(1):62-74. PubMed ID: 25763997
    [Abstract] [Full Text] [Related]

  • 43. Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1.
    Boutajangout A, Authelet M, Blanchard V, Touchet N, Tremp G, Pradier L, Brion JP.
    Neurobiol Dis; 2004 Feb 14; 15(1):47-60. PubMed ID: 14751770
    [Abstract] [Full Text] [Related]

  • 44. Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration.
    Amadoro G, Corsetti V, Atlante A, Florenzano F, Capsoni S, Bussani R, Mercanti D, Calissano P.
    Neurobiol Aging; 2012 Apr 14; 33(4):833.e1-25. PubMed ID: 21958963
    [Abstract] [Full Text] [Related]

  • 45. Changes in amyloid-β and Tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein.
    Maia LF, Kaeser SA, Reichwald J, Hruscha M, Martus P, Staufenbiel M, Jucker M.
    Sci Transl Med; 2013 Jul 17; 5(194):194re2. PubMed ID: 23863834
    [Abstract] [Full Text] [Related]

  • 46. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.
    Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E.
    Science; 2001 Aug 24; 293(5534):1487-91. PubMed ID: 11520987
    [Abstract] [Full Text] [Related]

  • 47. Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer's Mouse Model of Amyloid Deposition.
    Chen C, Wei J, Ma X, Xia B, Shakir N, Zhang JK, Zhang L, Cui Y, Ferguson D, Qiu S, Bai F.
    Neurosci Bull; 2023 Jun 24; 39(6):881-892. PubMed ID: 36152121
    [Abstract] [Full Text] [Related]

  • 48. [Generation of Tau/App/PS1 triple-transgenic mouse model and the study of its biological characteristics].
    Wang LL, Na X, Zhu XN, Chen RZ, Wang H, Wang XL.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 Jul 24; 28(4):294-7. PubMed ID: 23156717
    [Abstract] [Full Text] [Related]

  • 49. Disrupted cross-laminar cortical processing in β amyloid pathology precedes cell death.
    Lison H, Happel MF, Schneider F, Baldauf K, Kerbstat S, Seelbinder B, Schneeberg J, Zappe M, Goldschmidt J, Budinger E, Schröder UH, Ohl FW, Schilling S, Demuth HU, Scheich H, Reymann KG, Rönicke R.
    Neurobiol Dis; 2014 Mar 24; 63():62-73. PubMed ID: 24291517
    [Abstract] [Full Text] [Related]

  • 50. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
    Tackenberg C, Kulic L, Nitsch RM.
    PLoS One; 2020 Mar 24; 15(9):e0239584. PubMed ID: 32966331
    [Abstract] [Full Text] [Related]

  • 51. Physiological expression of mutated TAU impaired astrocyte activity and exacerbates β-amyloid pathology in 5xFAD mice.
    Farfara D, Sooliman M, Avrahami L, Royal TG, Amram S, Rozenstein-Tsalkovich L, Trudler D, Blanga-Kanfi S, Eldar-Finkelman H, Pahnke J, Rosenmann H, Frenkel D.
    J Neuroinflammation; 2023 Jul 26; 20(1):174. PubMed ID: 37496076
    [Abstract] [Full Text] [Related]

  • 52. Histological and Behavioral Phenotypes of a Novel Mutated APP Knock-In Mouse.
    Plucińska K, Crouch B, Yeap JM, Stoppelkamp S, Riedel G, Platt B.
    J Alzheimers Dis; 2018 Jul 26; 65(1):165-180. PubMed ID: 30040726
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse.
    Ontiveros-Torres MÁ, Labra-Barrios ML, Díaz-Cintra S, Aguilar-Vázquez AR, Moreno-Campuzano S, Flores-Rodríguez P, Luna-Herrera C, Mena R, Perry G, Florán-Garduño B, Luna-Muñoz J, Luna-Arias JP.
    J Alzheimers Dis; 2016 Mar 22; 52(1):243-69. PubMed ID: 27031470
    [Abstract] [Full Text] [Related]

  • 56. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA, Hipp SA, Rijal Upadhaya A, Balakrishnan K, Ospitalieri S, Koper MJ, Largo-Barrientos P, Uytterhoeven V, Reichwald J, Rabe S, Vandenberghe R, von Arnim CAF, Tousseyn T, Feederle R, Giudici C, Willem M, Staufenbiel M, Thal DR.
    Acta Neuropathol; 2019 Dec 22; 138(6):913-941. PubMed ID: 31414210
    [Abstract] [Full Text] [Related]

  • 57. Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment.
    Watamura N, Toba J, Yoshii A, Nikkuni M, Ohshima T.
    J Neurosci Res; 2016 Jan 22; 94(1):15-26. PubMed ID: 26400044
    [Abstract] [Full Text] [Related]

  • 58. Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
    Kurt MA, Davies DC, Kidd M, Duff K, Howlett DR.
    Neurobiol Dis; 2003 Oct 22; 14(1):89-97. PubMed ID: 13678670
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Evidence for altered Numb isoform levels in Alzheimer's disease patients and a triple transgenic mouse model.
    Chigurupati S, Madan M, Okun E, Wei Z, Pattisapu JV, Mughal MR, Mattson MP, Chan SL.
    J Alzheimers Dis; 2011 Oct 22; 24(2):349-61. PubMed ID: 21258150
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.